how many americans take glp-1 drugs people glp 1 for Addiction: the Medical Evidence for Opioid Ozempic Statistics: GLP-1 Weight Loss
Description
Ozempic is the stronger choice for weight loss (up to 15% of body weight) and A1C reduction (-1.8%), while Farxiga excels in heart failure prevention (-30% hospitalizations) and chronic kidney disease protection (-39% progression)
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes
61 Bezin et al
Mol Metab 30:72130 Kabahizi A et al (2022) Glucagon-like peptide-1 (GLP-1) signalling in the brain: from neural circuits and metabolism to therapeutics
Indication 18.8.7
J., Orskov C., Nielsen O
